These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3222201

  • 1. Mechanism of bone and cartilage maldevelopment in the warfarin embryopathy.
    Pauli RM.
    Pathol Immunopathol Res; 1988; 7(1-2):107-12. PubMed ID: 3222201
    [No Abstract] [Full Text] [Related]

  • 2. Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolism.
    Menger H, Lin AE, Toriello HV, Bernert G, Spranger JW.
    Am J Med Genet; 1997 Oct 17; 72(2):129-34. PubMed ID: 9382132
    [Abstract] [Full Text] [Related]

  • 3. Male infant with ichthyosis, Kallmann syndrome, chondrodysplasia punctata, and an Xp chromosome deletion.
    Bick D, Curry CJ, McGill JR, Schorderet DF, Bux RC, Moore CM.
    Am J Med Genet; 1989 May 17; 33(1):100-7. PubMed ID: 2750777
    [Abstract] [Full Text] [Related]

  • 4. Warfarin embryopathy in siblings.
    Harrod MJ, Sherrod PS.
    Obstet Gynecol; 1981 May 17; 57(5):673-6. PubMed ID: 7194462
    [Abstract] [Full Text] [Related]

  • 5. Warfarin embryopathy--a case report.
    Lamontagne JM, Leclerc JE, Carrier C, Bureau M.
    J Otolaryngol; 1984 Apr 17; 13(2):127-9. PubMed ID: 6726847
    [Abstract] [Full Text] [Related]

  • 6. Chondrodysplasia Punctata: A Case Report of Fetal Warfarin Syndrome.
    Songmen S, Panta OB, Paudel SS, Ghimire RK.
    J Nepal Health Res Counc; 2017 Jan 17; 15(1):81-84. PubMed ID: 28714498
    [Abstract] [Full Text] [Related]

  • 7. Common phenotype and etiology in warfarin embryopathy and X-linked chondrodysplasia punctata (CDPX).
    Savarirayan R.
    Pediatr Radiol; 1999 May 17; 29(5):322. PubMed ID: 10382206
    [No Abstract] [Full Text] [Related]

  • 8. [The VKOR target for warfarin identified].
    Le Bonniec B.
    Med Sci (Paris); 2004 May 17; 20(5):512-4. PubMed ID: 15190465
    [No Abstract] [Full Text] [Related]

  • 9. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats.
    Tanaka KD, Kawai YK, Ikenaka Y, Harunari T, Tanikawa T, Fujita S, Ishizuka M.
    J Vet Med Sci; 2013 Feb 17; 75(2):135-9. PubMed ID: 23018795
    [Abstract] [Full Text] [Related]

  • 10. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug 17; 41(8):253-4. PubMed ID: 6355923
    [No Abstract] [Full Text] [Related]

  • 11. Temporal variation in the effects of warfarin on the vitamin K cycle.
    Soulban G, Labrecque G, Bélanger PM.
    Chronobiol Int; 1990 Aug 17; 7(5-6):403-11. PubMed ID: 2097073
    [Abstract] [Full Text] [Related]

  • 12. Warfarin and the vitamin K-dependent gamma-carboxylation system.
    Wallin R, Hutson SM.
    Trends Mol Med; 2004 Jul 17; 10(7):299-302. PubMed ID: 15242675
    [Abstract] [Full Text] [Related]

  • 13. [Warfarin fetopathy].
    Bony C, Zyka F, Tiran-Rajaofera I, Attali T, De Napoli S, Alessandri JL.
    Arch Pediatr; 2002 Jul 17; 9(7):705-8. PubMed ID: 12162160
    [Abstract] [Full Text] [Related]

  • 14. Identification of VKORC1 interaction partners by split-ubiquitin system and coimmunoprecipitation.
    Schaafhausen A, Rost S, Oldenburg J, Müller CR.
    Thromb Haemost; 2011 Feb 17; 105(2):285-94. PubMed ID: 21103663
    [Abstract] [Full Text] [Related]

  • 15. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
    Miyake N, Hoshi K, Sano Y, Kikuchi K, Tadano K, Koshihara Y.
    Osteoporos Int; 2001 Feb 17; 12(8):680-7. PubMed ID: 11580082
    [Abstract] [Full Text] [Related]

  • 16. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ, Principe LM, Fasco MJ.
    Biochemistry; 1985 Dec 03; 24(25):7063-70. PubMed ID: 4084561
    [Abstract] [Full Text] [Related]

  • 17. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
    Uitendaal MP, Thijssen HH, Drittij-Reijnders MJ, Hoeijmakers MJ.
    Biochem Biophys Res Commun; 1986 Jun 30; 137(3):1015-20. PubMed ID: 3729947
    [Abstract] [Full Text] [Related]

  • 18. Vitamin K antagonist rodenticides display different teratogenic activity.
    Chetot T, Taufana S, Benoit E, Lattard V.
    Reprod Toxicol; 2020 Apr 30; 93():131-136. PubMed ID: 32045655
    [Abstract] [Full Text] [Related]

  • 19. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR, Sauer JM, Carlson GP, Wallin R, Ward MP, Hooser SB.
    Toxicology; 2003 Aug 01; 189(3):191-8. PubMed ID: 12832152
    [Abstract] [Full Text] [Related]

  • 20. Warfarin embryopathy: fetal manifestations.
    Wainwright H, Beighton P.
    Virchows Arch; 2010 Dec 01; 457(6):735-9. PubMed ID: 20922410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.